joimax® turns 15 years

Karlsruhe, Germany and Chicago, Illinois (April 30, 2016) – joimax^®, the global acting German developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, is celebrating its 15^th anniversary worldwide in 2016 starting at AANS in Chicago combined with a joimax^® Senior Faculty Meeting. The aim of this meeting is to share experience, deepen expertise, specifically in reference to the newest joimax^® products and applications as well as to refine the specific surgical techniques. Key topics will be centered around endoscopic treatment of degenerative spine diseases.

“When I started with the TESSYS^® system in 2006 I was wondering at which patient indications this system could be applied”, says Daniel Laich, DO at Swedish Covenant Hospital in Chicago, Il.
“Now we are doing all kind of special stenotic cases and even thoracic disc, or even tumor treatments”, continues Albert Telfeian, MD, PhD at the Hasbro Hospital of The Warren Alpert Medical School at Brown University, Rhode Island.
“With the iLESSYS^® Delta System I can even do an over-the-top decompression in a central stenotic patient and with the EndoLIF^® method I do an endoscopic assisted stabilization if indicated” finishes Ralf Wagner, MD from the Ligamenta Spine Center in Frankfurt, Germany.

joimax^®, entirely focused on treatment technologies for endoscopic minimally-invasive spinal surgery, over the years launched more than 10 different indication driven systems providing a company growth rate of over 35% per annum. To date more than 180.000 patients had been treated in over 40 countries with the various methods, based on more than 140 patents and trademarks issued globally. “The major company growth and market evolutional steps are further out in front of the companies’ future, based on solid ground with broad market adoption starting just now”, states Wolfgang Ries, CEO and founder of joimax^®.